All In MedTech

Device Trial Radar · NCT02463279

SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study

Last checked: Nov 20, 2026Latest source record: Dec 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Apr 2015

Primary completion

Oct 2015

Study completion Mar 2016

Sponsor

Lead sponsor
SinuSys CorporationNot on our public-company list
Sponsor type
Industry
First posted
Jun 4, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate basic usability and confirm expected safety and effectiveness of SinuSys Dilation System when used to dilate frontal recess and sphenoid sinus ostia in patients with chronic rhinosinusitis.

Conditions

  • Sinusitis

Interventions

  • Sinusys Dilation SystemDevice

    Dilation of frontal recess and/or sphenoid sinus ostia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patency of treated target siteTime frame: Patency immediately post device expansion and removal

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Upland ENT

    Upland, California

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.